B J Rembacken

Summary

Country: UK

Publications

  1. ncbi Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary, Leeds
    Lancet 355:1211-4. 2000
  2. ncbi Endoscopic mucosal resection
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, United Kingdom
    Endoscopy 33:709-18. 2001
  3. ncbi Endoscopic therapy of lower gastrointestinal cancer
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, Great George Street, UK
    Best Pract Res Clin Gastroenterol 19:979-92. 2005
  4. ncbi Images of early rectal cancer
    B J Rembacken
    Dept. of Gastroenterology, Centre for Digestive Diseases, General Infirmary at Leeds, Leeds, United Kingdom
    Endoscopy 36:223-33. 2004
  5. ncbi Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, UK
    Lancet 354:635-9. 1999
  6. ncbi Characterization of colonic polyps at conventional (nonmagnifying) colonoscopy after spraying with 0.2 % indigo carmine dye
    S Sonwalkar
    Centre for Digestive Diseases, Department of Gastroenterology, General Infirmary at Leeds, Leeds, UK
    Endoscopy 38:1218-23. 2006
  7. ncbi Acute toxic gastric mucosal damage induced by Lugol's iodine spray during chromoendoscopy
    A Sreedharan
    Gut 54:886-7. 2005
  8. ncbi Images of early gastric cancer
    R Murai
    Dept. of Surgery, Tokyu Hospital, Tokyo, Japan
    Endoscopy 35:598-605. 2003
  9. ncbi BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias
    K Konishi
    Second Department of Internal Medicine, Showa University School of Medicine, 1 5 8 Hatanodai, Shinagawa ku, Tokyo 142 8666, Japan
    Br J Cancer 94:311-7. 2006
  10. ncbi Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth
    K Kaneko
    Second Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan
    Br J Cancer 91:312-8. 2004

Collaborators

  • S Kudo
  • T Matsumoto
  • Kazuhiro Kaneko
  • Hiroaki Nozawa
  • S Sonwalkar
  • K Konishi
  • O Rotimi
  • A Sreedharan
  • R Murai
  • M Kusano
  • Y Hirayama
  • H Ota
  • M Takimoto
  • Y Kumekawa
  • N Yoshikawa
  • T Yamamoto
  • K Nakayama
  • R Makino
  • M Imawari
  • H Ito
  • T Kurahashi
  • S Nimura
  • J Fujisaki
  • A Chonan
  • T Gotoda
  • T Shimoda
  • A Okano
  • H Takakuwa
  • A Nishio

Detail Information

Publications10

  1. ncbi Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary, Leeds
    Lancet 355:1211-4. 2000
    ..Flat and depressed colorectal tumours were originally thought to be unique to the Japanese population. Recently there have been reports of flat and depressed lesions in western countries but they have been thought to be uncommon...
  2. ncbi Endoscopic mucosal resection
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, United Kingdom
    Endoscopy 33:709-18. 2001
    ..The risk of developing metastatic disease can then be balanced against the risks of surgery in view of the patient's age and health...
  3. ncbi Endoscopic therapy of lower gastrointestinal cancer
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, Great George Street, UK
    Best Pract Res Clin Gastroenterol 19:979-92. 2005
    ..This chapter discusses the main issues surrounding the endoscopic therapy of lower gastrointestinal cancers...
  4. ncbi Images of early rectal cancer
    B J Rembacken
    Dept. of Gastroenterology, Centre for Digestive Diseases, General Infirmary at Leeds, Leeds, United Kingdom
    Endoscopy 36:223-33. 2004
  5. ncbi Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
    B J Rembacken
    Centre for Digestive Diseases, The General Infirmary at Leeds, UK
    Lancet 354:635-9. 1999
    ..coli (Nissle 1917) was as effective as mesalazine in preventing relapse of ulcerative colitis. We also examined whether the addition of E. coli to standard medical therapy increased the chance of remission of active ulcerative colitis...
  6. ncbi Characterization of colonic polyps at conventional (nonmagnifying) colonoscopy after spraying with 0.2 % indigo carmine dye
    S Sonwalkar
    Centre for Digestive Diseases, Department of Gastroenterology, General Infirmary at Leeds, Leeds, UK
    Endoscopy 38:1218-23. 2006
    ..Magnification is not always necessary to distinguish neoplastic from nonneoplastic colonic lesions. This finding could result in resource savings in colonoscopic screening...
  7. ncbi Acute toxic gastric mucosal damage induced by Lugol's iodine spray during chromoendoscopy
    A Sreedharan
    Gut 54:886-7. 2005
  8. ncbi Images of early gastric cancer
    R Murai
    Dept. of Surgery, Tokyu Hospital, Tokyo, Japan
    Endoscopy 35:598-605. 2003
  9. ncbi BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias
    K Konishi
    Second Department of Internal Medicine, Showa University School of Medicine, 1 5 8 Hatanodai, Shinagawa ku, Tokyo 142 8666, Japan
    Br J Cancer 94:311-7. 2006
    ..Abnormal accumulation of p-MAPK protein is more likely to be implicated in the tumorigenesis of FDNs than of PNs. However, this abnormality in FDNs might occur via the genetic alteration other than BRAF or KRAS mutation...
  10. ncbi Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth
    K Kaneko
    Second Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan
    Br J Cancer 91:312-8. 2004
    ..Assuming that some nonpolypoid growth lesions transform rapidly into advanced carcinomas, 20% of all colorectal carcinomas may progress in this manner...